LivingGLP1
parallel randomized trial

NCT00993720

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

Design

Randomized
20
Start year
2009
Treatment
4 weeks, follow-up 4 weeks
Countries
Denmark
Sponsor
Hvidovre University Hospital (non industry)
Eligibility
age 18 to 50; BMI 18 to 27; HbA1c up to 8.5; randomized part C-peptide negative

Conduct and analysis

Blinding
open label
Sequence generation
computer
Allocation concealment
pharmacy or sealed
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
modified itt
Missing data
not reported

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Liraglutide 1.2 mg subcutaneous once daily
Liraglutide plus insulin (C-peptide negative)
basal bolus insulin reduced at start then titrated to glucose target; lifestyle: none9
A2Standard care or no added treatment
Insulin alone (C-peptide negative)
basal bolus insulin titrated to glucose 5 to 7 mmol/L; lifestyle: none10

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticLiraglutide 1.2 mg subcutaneous once daily
A1
Standard care or no added treatment
A2
agemean (years)35.732.9
agese (years)2.21.7
bmimean (kg/m2)24.623.1
bmise (kg/m2)0.70.6
diabetes durationmean (years)17.323.1
diabetes durationse (years)2.51.6
femalen01
hba1cmean (percent)7.57.1
hba1cse (percent)0.20.3
insulin dosemean (U/kg/day)0.720.62
insulin dosese (U/kg/day)0.080.04

Results

12 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (4 lines; O01)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
4A1change-0.47 percent0.159not stated; modified itt; R0027162:Results
4A1final7.0 percent0.19not stated; modified itt; R0027162:Table 1
4A2change-0.18 percent0.110not stated; modified itt; R0027162:Results
4A2final6.9 percent0.210not stated; modified itt; R0027162:Table 1
Total daily insulin dose change (5 lines; O06)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
4A1change-0.13 U/kg/day0.049not stated; modified itt; R0027162:Results
4A1final0.59 U/kg/day0.069not stated; modified itt; R0027162:Table 1
4A1percent change-15.8 percent5.59not stated; modified itt; R0027162:Results
4A2change0.017 U/kg/day0.0210not stated; modified itt; R0027162:Results
4A2final0.64 U/kg/day0.0510not stated; modified itt; R0027162:Table 1
Nausea (1 lines; O27A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A2events0 / 10not stated; modified itt; R0027162:Results
Vomiting (1 lines; O27B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A2events0 / 10not stated; modified itt; R0027162:Results
Diarrhea (1 lines; O27C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A2events0 / 10not stated; modified itt; R0027162:Results